Reckitt Benckiser Group Plc (RB.):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Reckitt Benckiser Group Plc (RB.) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9918
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Reckitt Benckiser Group Plc (RB) is a consumer health and hygiene company that manufactures and markets household, toiletry and health care products. These consist of air fresheners, laundry products, dishwashing detergents, disinfectant sprays, water softeners, household cleaners, and personal care products. It also sells over-the-counter (OTC) drugs, cough and congestion tablets. Sinus relief products, gastric liquids, hair removal and pest control products. The company markets these products under various Powerbrands including Nurofen, Strepsils, Mucinex, Dettol, Lysol, Veet, Harpic, Mortein, Finish and Vanish, for a few. It has operations across Asia Pacific, Europe, North America and the Middle East and Africa regions. RB is headquartered in Slough, Berkshire, the UK.

Reckitt Benckiser Group Plc (RB.) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Reckitt Benckiser Group Plc, Medical Devices Deals, 2012 to YTD 2018 10
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Reckitt Benckiser Exercises Option to Acquire OTC Products of Bristol-Myers Squibb for USD317 Million 12
Reckitt Benckiser To Acquire K-Y Lubricants Brand From McNEIL-PPC 14
Partnerships 15
Mead Johnson Nutrition Forms Joint Venture With Sancor Cooperativas Unidas 15
Licensing Agreements 17
Reckitt Benckiser Amends Licensing Agreement With Bristol-Myers Squibb For OTC Brands 17
Asset Transactions 19
G.R. Lane Health Products Acquires Derbac M and Earex Brands From Reckitt Benckiser 19
Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For US$4 Million 20
Acquisition 21
Reckitt Benckiser Plans To Sell Reckitt Benckiser Pharma For US$3.2 Billion 21
Reckitt Benckiser Completes Acquisition Of Schiff Nutrition International For US$1.4 Billion 22
SSL International Acquires Remaining 25% Stake In Beleggingsmaatschappij Lemore 24
Reckitt Benckiser Group Plc – Key Competitors 25
Reckitt Benckiser Group Plc – Key Employees 26
Reckitt Benckiser Group Plc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 30
Financial Announcements 30
Feb 19, 2018: Reckitt Benckiser reports full year 2017 results 30
Jul 24, 2017: Reckitt Benckiser reports half year 2017 results 33
Legal and Regulatory 34
Mar 08, 2017: Absorption Pharmaceuticals: Maker of Premature Ejaculation Medication Promescent Files Suit Against British Conglomerate for Trade Secret Theft and Fraud 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Reckitt Benckiser Group Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Reckitt Benckiser Group Plc, Medical Devices Deals, 2012 to YTD 2018 10
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Reckitt Benckiser Exercises Option to Acquire OTC Products of Bristol-Myers Squibb for USD317 Million 12
Reckitt Benckiser To Acquire K-Y Lubricants Brand From McNEIL-PPC 14
Mead Johnson Nutrition Forms Joint Venture With Sancor Cooperativas Unidas 15
Reckitt Benckiser Amends Licensing Agreement With Bristol-Myers Squibb For OTC Brands 17
G.R. Lane Health Products Acquires Derbac M and Earex Brands From Reckitt Benckiser 19
Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For US$4 Million 20
Reckitt Benckiser Plans To Sell Reckitt Benckiser Pharma For US$3.2 Billion 21
Reckitt Benckiser Completes Acquisition Of Schiff Nutrition International For US$1.4 Billion 22
SSL International Acquires Remaining 25% Stake In Beleggingsmaatschappij Lemore 24
Reckitt Benckiser Group Plc, Key Competitors 25
Reckitt Benckiser Group Plc, Key Employees 26
Reckitt Benckiser Group Plc, Subsidiaries 27

List of Figures
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Reckitt Benckiser Group Plc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Reckitt Benckiser Group Plc (RB.):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Qisda Corporation:戦略・SWOT・企業財務分析
    Qisda Corporation - Strategy, SWOT and Corporate Finance Report Summary Qisda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Electricity & Water Authority:企業の戦略的SWOT分析
    Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Immunodiagnostic Systems Holdings plc (IDH):企業の財務・戦略的SWOT分析
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • GSE Systems Inc (GVP):電力:M&Aディール及び事業提携情報
    Summary GSE Systems Inc (GSE) is a provider of real-time high-fidelity simulation. The company offers a wide range of simulation, training, consulting, and engineering solutions. Its simulation, engineering, and plant services assist customers in achieving performance excellence in design, training, …
  • Breathe Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Breathe Technologies Inc (Breathe Technologies) is a home health care service provider that manufactures and develops innovative medical technologies for patients with respiratory insufficiency and neuromuscular diseases. The company offers research, development and production of new therape …
  • Holtec International Inc:企業の戦略的SWOT分析
    Holtec International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • IDG Communications Inc:企業の戦略的SWOT分析
    IDG Communications Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • National Cheng Kung University:製薬・医療:M&Aディール及び事業提携情報
    Summary National Cheng Kung University (NCKU) is a research-led comprehensive university that offers educational and research services. The university’s services include graduate, undergraduate and postgraduate courses, research programs, master's programs, degree programs, doctoral courses, doctor' …
  • IDEXX Laboratories, Inc.:企業の戦略・SWOT・財務情報
    IDEXX Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report Summary IDEXX Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Charles River Laboratories International Inc (CRL):製薬・医療:M&Aディール及び事業提携情報
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • Pakistan Water and Power Development Authority:電力:M&Aディール及び事業提携情報
    Summary Pakistan Water and Power Development Authority (WAPDA) is a government-owned public authority maintaining power and water in Pakistan. It is responsible for the development of hydel power and water sector projects in Pakistan. The authority plans and executes projects and schemes for the gen …
  • State Bank Of India
    State Bank Of India - Strategy, SWOT and Corporate Finance Report Summary State Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Air Transport Services Group, Inc.:戦略・SWOT・企業財務分析
    Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • EnServe Group Limited:企業のM&A・事業提携・投資動向
    EnServe Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnServe Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Analyticon Biotechnologies AG:企業の製品パイプライン分析2018
    Summary Analyticon Biotechnologies AG (Analyticon), a subsidiary of Analyticon Discovery GmbH, is a medical device company that develops, manufactures, and distributes diagnostic systems. The company provides products in the areas of urine diagnostics, clinical chemistry, coagulation, and hematology …
  • SBS Transit Ltd.:企業の戦略・SWOT・財務情報
    SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report Summary SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Mercuria Energy Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Mercuria Energy Group Ltd (Mercuria Energy) is an independent energy and commodity company that carries out sourcing, supplying and trading of crude oil and refined petroleum products through its subsidiaries. Its portfolio includes petrochemicals, biofuels, environmental products, natural g …
  • Impel NeuroPharma Inc:医療機器:M&Aディール及び事業提携情報
    Summary Impel NeuroPharma Inc (Impel) is a clinical-stage biotechnology company that which develops intranasal drug treatments for central nervous system disorders. The company’s product pipeline includes INP104, INP103, INP102, INP101, INP105, and INP106. It also develops Precision Olfactory Delive …
  • Oric Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oric Pharmaceuticals Inc (Oric Pharmaceuticals) is an independent oncology company that focuses to discover and develop drugs for overcoming resistance in cancer. Its lead drug candidate ORIC-101, which is in phase 1 clinical trial, is a small molecule inhibitor of the glucocorticoid recepto …
  • Texas A&M University:製薬・医療:M&Aディール及び事業提携情報
    Summary Texas A&M University (TAMU) is a research based university that provide educational and research services. The university offers undergraduate, graduate and professional courses to its students. It consists of various colleges and departments such as College of Agriculture and Life Sciences, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆